N-methyl-N-acylglucamine-containing composition

Information

  • Patent Grant
  • 10864275
  • Patent Number
    10,864,275
  • Date Filed
    Wednesday, May 29, 2013
    11 years ago
  • Date Issued
    Tuesday, December 15, 2020
    3 years ago
Abstract
The invention relates to a composition which contains at least one anionic surfactant, a betaine surfactant, a mixture of N-methyl-N-acylglucamines, the acyl groups of which correspond to those of natural coconut oil and/or palm kernel oil, a glycerol derivative, a solvent and optionally one or more additives. The invention also relates to a method for producing the composition. The invention further relates to the use of the composition for the treatment or care of skin or hair, for example as a shampoo, face cleaner, liquid cleaner or shower gel.
Description

The invention relates to a composition comprising at least one anionic surfactant, a betaine surfactant, a mixture of N-methyl-N-acylglucamines, a glycerol derivative, a solvent, and optionally one or more additives, and to a method for preparing the composition. The invention relates further to the use of the composition for the treatment or care of the skin or hair, for example as a shampoo, facial cleanser, liquid cleanser or shower gel.


In the preparation of compositions, in particular the preparation of cleansing compositions, a number of criteria are to be observed, such as, for example, a good cleansing action, adequate foaming properties, good skin tolerability, a good feel in relation to the skin, hair and especially no irritation of the mucosa. Skin and hair consist of a plurality of layers which comprise inter alia keratin and collagen as fiber proteins. Anionic surfactants can penetrate the layers and damage them. Ideal cleansing agents for cosmetic or pharmaceutical applications should gently clean the skin or the hair without removing oil from and/or drying the hair and the skin and without causing irritation. Most foaming soaps, shower and bath additives, shampoos and cosmetics fail in this regard or exhibit correspondingly poor foaming behavior.


EP 0 550 637 A1 describes a process for preparing polyhydroxy fatty acid amide materials which can be used inter alia as surfactants. The process is particularly useful when the N-alkylpolyhydroxyamine has the formula N(R1)CH2(CH2OH)4CH2OH. A C12-C20-fatty acid methyl ester is preferably used in the process. A preferred process for preparing detergent surfactants is one in which the N-alkylpolyhydroxyamine is an N-methylglucoamine, the fatty acid ester is a C12-C20-methyl ester or a mixture thereof, the solvent is methanol, and the catalyst is sodium methoxide.


Document WO 92/06158 relates to a low-foam detergent composition comprising at least 1% by weight of a polyhydroxy fatty acid amide surfactant of the formula




embedded image



wherein R1 is H, C1-C4-hydrocarbon, 2-hydroxyethyl or 2-hydroxypropyl, R2 is C5-C31-hydrocarbon, and Z is a polyhydroxy hydrocarbon having a linear hydrocarbon chain with at least three hydroxyl groups bonded directly to the chain, or alkoxylated derivatives thereof; at least 1% of an alkylalkoxylated sulfate surfactant; and optionally a foam-suppressing amount of a foam suppressor which is chosen from monocarboxylic fatty acids and salts thereof, silicone foam suppressors and monostearyl kiakali metal phosphates or phosphate esters, and high molecular weight hydrocarbon foam suppressors and mixtures thereof; wherein the composition has an alkylalkoxylated sulfate:polyhydroxy fatty acid amide weight ratio of from 10:1 to 1:10, preferably from 5:1 to 1:5 and more preferably from 4:1 to 1:1 and the polyhydroxy fatty acid amide comprises less than 4% by weight of a cyclic amide secondary product.


WO 98/56496 relates to a surfactant composition having improved foam stability. The surfactant composition comprises: (a) from approximately 1 to approximately 40% by weight of a sugar-based surfactant; (b) from approximately 1 to approximately 40% by weight of an anionic surfactant; (c) from approximately 0.11 to approximately 10% by weight of an amphoacetate; and (d) remainder water, wherein the amounts by weight are based on the weight of the composition.







Accordingly, the object of the invention is to provide improved compositions, in particular with regard to improved foam behavior.


Surprisingly, it has been found that formulations comprising N-acyl-N-methylglucamines having a chain distribution of natural coconut oil or palm kernel oil are superior in terms of the foam properties to the C12/14 N-acyl-N-methylglucamines mentioned in WO 92/06158. N-Acyl-N-methylglucamines that have been prepared from triglyceride oil and accordingly comprise glycerol and small amounts of glycerol derivatives exhibit particular advantages.


There is accordingly provided a composition comprising:

    • (A) at least one anionic surfactant as component A,
    • (B) at least one betaine surfactant as component B selected from the group consisting of an alkyl betaine, an alkylamido betaine and mixtures thereof,
    • (C) a mixture of N-methyl-N-acylglucamines as component C, wherein the N-methyl-N-acylglucamines have a C8-C22-acyl radical and the distribution of the C8-C22-acyl radicals corresponds to that of natural coconut oil or palm kernel oil or a mixture of the two,
    • (D) at least one glycerol derivative as component D, selected from the group consisting of glycerol, monoglycerides, diglycerides, triglycerides, wherein the glycerides in question have at least one C8-C22-acyl radical, and mixtures thereof,
    • (E) at least one solvent as component E, and
    • (F) optionally one or more additives as component F.


The composition according to the invention is distinguished in particular by a synergistic action of components C and D. As is apparent from the comparative example, a composition without component D does not lead to the same effect as the composition according to the invention. This can be attributed to the fact that the products formed in the reaction of a triglyceride and an N-methylglucamine, in particular in their specific ratio, surprisingly lead to the improved properties.


The anionic surfactant of component A can be, for example, an amino acid surfactant. Preference is given to acyl glycinates, acyl alaninates, acyl aspartates, acyl glutamates and acyl sarcosinates, in particular sodium cocoyl glycinate, potassium cocoyl glycinate, sodium lauroyl glycinate, potassium lauroyl glycinate, sodium cocoyl glutamate, sodium lauroyl glutamate, sodium cocoyl aspartate, sodium lauroyl aspartate and sodium lauroyl sarcosinate.


In a preferred embodiment, component A is selected from one or more compound(s) of formula (I)

R1SO3M+  (I)

wherein R1 represents alkyl, cycloalkyl, aralkyl, aryl, alkoxy, alkoxyalkyl or heterocyclyl and M+ is an alkali metal, alkaline earth metal or substituted or unsubstituted ammonium ion,


and/or of formula (II)

R1SO4M+  (II)

wherein R1 represents alkyl, cycloalkyl, aralkyl, aryl, alkoxy, alkoxyalkyl and heterocyclyl and M+ is an alkali metal, alkaline earth metal or substituted or unsubstituted ammonium ion.


“Alkyl” denotes a saturated aliphatic hydrocarbon group which can be straight-chained or branched and can have from 1 to 20 carbon atoms in the chain. Preferred alkyl groups can be straight-chained or branched and have from 1 to 10 carbon atoms in the chain. Branched means that a lower alkyl group, such as methyl, ethyl or propyl, is attached to a linear alkyl chain. Alkyl is, for example, methyl, ethyl, 1-propyl, 2-propyl, 1-butyl, 2-butyl, 2-methyl-1-propyl (isobutyl), 2-methyl-2-propyl (tert-butyl), 1-pentyl, 2-pentyl, 3-pentyl, 2-methyl-1-butyl, 3-methyl-1-butyl, 2-methyl-2-butyl, 3-methyl-2-butyl, 2,2-dimethyl-1-propyl, 1-hexyl, 2-hexyl, 3-hexyl, 2-methyl-1-pentyl, 3-methyl-1-pentyl, 4-methyl-1-pentyl, 2-methyl-2-pentyl, 3-methyl-2-pentyl, 4-methyl-2-pentyl, 2-methyl-3-pentyl, 3-methyl-3-pentyl, 2,2-dimethyl-1-butyl, 2,3-dimethyl-1-butyl, 3,3-dimethyl-1-butyl, 2-ethyl-1-butyl, 2,3-dimethyl-2-butyl, 3,3-dimethyl-2-butyl, 1-heptyl, 1-octyl, 1-nonyl, 1-decyl, 1-undecyl, 1-dodecyl, 1-tetradecyl, 1-hexadecyl and 1-octadecyl.


“Cycloalkyl” denotes an aliphatic ring which has from 3 to 10 carbon atoms in the ring. Preferred cycloalkyl groups have from 4 to 7 carbon atoms in the ring.


“Aryl” denotes phenyl or naphthyl.


“Aralkyl” denotes an alkyl group which is substituted by an aryl radical.


“Substituted aralkyl” and “substituted aryl” mean that the aryl group or the alkyl group of the aralkyl group is substituted by one or more substituents selected from alkyl, alkoxy, nitro, carboalkoxy, cyano, halo, alkylmercaptyl, trihaloalkyl or carboxyalkyl.


“Alkoxy” denotes an alkyl-0 group in which “alkyl” has the meaning described above. Lower alkoxy groups are preferred. Examples are methoxy, ethoxy, n-propoxy, isopropoxy and n-butoxy.


“Lower alkyl” denotes an alkyl group which has from 1 to 7 carbon atoms.


“Alkoxyalkyl” denotes an alkyl group as described above which is substituted by an alkoxy group as described above. Accordingly, the term alkoxyalkyl can be understood as including a polyether.


“Heterocyclyl” denotes a 4- to 10-membered ring structure in which one or more ring atoms are other than carbon, for example N, O or S. Heterocyclyl can be aromatic or non-aromatic, that is to say it can be saturated, partially saturated or completely unsaturated.


Particularly preferred as component A are sodium lauryl sulfate and/or sodium lauryl ether sulfate.


Component B is selected from the group consisting of at least one alkyl betaine, alkylamido betaine or mixtures thereof.


Examples of suitable alkyl betaines are the carboxyalkylation products of secondary and in particular tertiary amines of formula (III)




embedded image



wherein R2 represents alkyl and/or alkenyl radicals having from 6 to 22 carbon atoms, R3 represents hydrogen or alkyl radicals having from 1 to 4 carbon atoms, R4 represents hydrogen or alkyl radicals having from 1 to 4 carbon atoms, n represents numbers from 1 to 6, and Z represents an alkali and/or alkaline earth metal or ammonium. Typical examples are the carboxymethylation products of hexylmethylamine, hexyldimethylamine, octyldimethylamine, decyldimethylamine, dodecylmethylamine, dodecyl-dimethylamine, dodecylethylmethylamine, C12/14-coco alkyldimethyl-amine, myristyldimethylamine, cetyldimethylamine, stearyldimethylamine, stearylethylmethylamine, oleyldimethylamine, C16/18-tallow alkyldimethyl-amine and commercial mixtures thereof.


Examples of suitable alkylamido betaines are carboxyalkylation products of amidoamines. Particularly suitable are amidopropyl betaines of formula (IV)




embedded image



wherein R5 is a linear or branched saturated C7-C21-alkyl group or a linear or branched mono- or poly-unsaturated C7-C21-alkenyl group.


Preferred betaine surfactants are amidopropyl betaines such as cocoamidopropyl betaine (R5CO is the fatty acid radical of coconut oil, chain length C8-C18) and alkyl betaines such as coco-betaine (R2 is the alkyl radical of coconut oil, chain length C8-C18) or lauryl betaine (R2 is an alkyl radical of chain length C12 and C14).


For example and preferably, the N-methyl-N-acylglucamine mixture (C) can be prepared according to EP 0 550 637 from the corresponding triglycerides and N-methylglucamine in the presence of 1,2-propylene glycol as solvent. In a preferred embodiment, components (C) and (D) are formed by transamidation of the triglycerides coconut oil and/or palm kernel oil with N-methylglucamine.


Further terms for N-methyl-N-acylglucamine are N-methyl-N-1-deoxysorbitol fatty acid amide, N-acyl-N-methyl-glucamine, glucamide or N-methyl-N-alkylglucamide. N-Methyl-N-acylglucamine corresponds to formula (V), wherein R is an organic radical:




embedded image


According to the invention, R—CO corresponds to the C8-C22-acyl radicals of natural coconut oil and/or palm kernel oil.


In a preferred embodiment, the distribution of the C8-C22-acyl radicals in the N-methyl-N-acylglucamine mixture corresponds to that of natural coconut oil.


The distribution of the C8-C22-acyl radicals which corresponds to that of natural coconut oil corresponds to the C8-C22-fatty acids in coconut oil.


Coconut oil comprises triglycerides.


Coconut oil comprises


a) from 40 to 55% by weight lauric acid,


b) from 10 to 20% by weight myristic acid,


c) from 8 to 12% by weight palmitic acid,


d) from 6 to 12% by weight oleic acid, and


h) from 0 to 36% by weight further fatty acids,


wherein the sum of the fatty acids bonded to the triglyceride is 100% by weight.


Particularly preferably, coconut oil comprises


a) from 40 to 55% by weight lauric acid,


b) from 10 to 20% by weight myristic acid,


c) from 8 to 12% by weight palmitic acid,


d) from 6 to 12% by weight oleic acid,


e) from 5 to 10% by weight decanoic acid,


f) from 4 to 10% by weight octanoic acid,


g) from 1 to 3% by weight stearic acid, and


h) from 0 to 26% by weight further fatty acids,


wherein the sum of the fatty acids bonded to the triglyceride is 100% by weight.


In a further preferred embodiment, the distribution of the C8-C22-acyl radicals in the N-methyl-N-acylglucamine mixture corresponds to that of natural palm kernel oil.


The distribution of the C8-C22-acyl radicals which corresponds to that of natural palm kernel oil corresponds to the C8-C22-fatty acids in palm kernel oil. Palm kernel oil comprises triglycerides.


Palm kernel oil comprises


a) from 45 to 55% by weight lauric acid,


b) from 14 to 18% by weight myristic acid,


c) from 6 to 10% by weight palmitic acid,


d) from 10 to 17% by weight oleic acid, and


h) from 0 to 25% by weight further fatty acids,


wherein the sum of the fatty acids bonded to the triglyceride is 100% by weight.


Particularly preferably, palm kernel oil comprises


a) from 46 to 49% by weight lauric acid,


b) from 15 to 17% by weight myristic acid,


c) from 7 to 9% by weight palmitic acid,


d) from 13 to 15% by weight oleic acid,


e) from 1 to 3% by weight decanoic acid,


f) from 1 to 3% by weight octanoic acid,


g) from 2 to 4% by weight stearic acid, and


h) from 0 to 15% by weight further fatty acids,


wherein the sum of the fatty acids bonded to the triglyceride is 100% by weight.


In a further preferred embodiment, the distribution of the C8-C22-acyl radicals in the N-methyl-N-acylglucamine mixture corresponds to that of a mixture of natural coconut oil and palm kernel oil.


There are used as glycerol derivatives D preferably those formed in the transamidation of coconut oil and/or palm kernel oil with N-methylglucamine. Examples of further glycerol derivatives which come into consideration are triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C8-C30-fatty acids, in particular vegetable oils, such as sunflower oil, corn oil, soybean oil, rice oil, jojoba oil, babusscu oil, pumpkin oil, grapeseed oil, sesame oil, walnut oil, apricot oil, orange oil, wheatgerm oil, peach kernel oil, macadamia oil, avocado oil, sweet almond oil, meadow foam seed oil, castor oil, olive oil, groundnut oil, rapeseed oil and coconut oil, as well as synthetic triglyceride oils. Hardened triglycerides are also preferred according to the invention. Oils of animal origin, for example beef tallow, perhydrosqualene and lanolin, can also be used. In addition to the triglycerides, mono- and di-glycerides can also be used.


A solvent E within the scope of the present invention is preferably understood as being protic solvents such as water, C1-C8-alcohols, in particular C1-C6-alcohols, ethylene glycol, diethylene glycol, triethylene glycol or mixtures thereof, particular preference being given to water and/or ethanol or water and/or methanol. Of the C1-C6-alcohols, methanol, ethanol, isopropanol, n-butanol or sec-butanol are preferred.


The preferred solvent is water or mixtures of water and propylene glycol.


Within the scope of a preferred embodiment, the additives F—where present—are chosen from the group consisting of preservatives, fragrances, dyes, surfactants, water, oily substances, cationic polymers, film-forming agents, thickeners and gelling agents, superfatting agents, antimicrobial and biogenic active ingredients, moisture-donating substances, stabilizers, acids, lyes, activity enhancers and mixtures thereof, preferably in amounts of from 0.1 to 10.0% by weight, particularly preferably from 0.5 to 8.0% by weight, and in particular from 1.0 to 5.0% by weight.


Suitable preservatives are the preservatives listed in the relevant annex to the European cosmetic products legislation, for example phenoxyethanol, benzyl alcohol, parabens, benzoic acid and sorbic acid, particularly suitable are, for example, 1,3-bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione (Nipaguard® DMDMH), piroctone olamine, methylisothiazolinone or mixtures thereof, preferably piroctone, olamine and/or methylisothiazolinone.


As fragrances or perfumes or oils there can be used individual fragrance compounds, for example the synthetic products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type. Examples of fragrance compounds of the ester type are benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinyl acetate, phenylethyl acetate, linalyl benzoate, benzyl formate, ethylmethylphenyl glycinate, allylcyclohexyl propionate, styrallyl propionate and benzyl salicylate. The ethers include, for example, benzyl ethyl ether; the aldehydes include, for example, linear alkanals having from 8 to 18 carbon atoms, citral, citronellal, citronellyloxy acetaldehyde, cyclamen aldehyde, hydroxycitronellal, lilial and bourgeonal; the ketones include, for example, ionones, alpha-isomethylionone and methyl cedryl ketone; the alcohols include anethol, citronellol, eugenol, geranion, linalool, phenylethyl alcohol and terpineol; the hydrocarbons include mainly terpenes and balsams. Preference is given to the use of mixtures of different fragrances, which together produce a pleasant note.


Perfume oils can also comprise natural fragrance mixtures, as are obtainable from plant or animal sources, for example pine oil, citrus oil, jasmine oil, lily oil, rose oil or ylang-ylang oil. Ethereal oils of low volatility, which are mostly used as flavor components, are also suitable as perfume oils, for example salvia oil, chamomile oil, carnation oil, melissa oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiver oil, olibanum oil, galbanum oil and ladanum oil.


The desired viscosity of the compositions can be adjusted (increased or lowered) by adding thickeners and gelling agents. There come into consideration preferably cellulose ethers and other cellulose derivatives (for example carboxymethylcellulose, hydroxyethylcellulose), gelatin, starch and starch derivatives, sodium alginates, fatty acid polyethylene glycol esters, agar-agar, tragacanth or dextrin derivatives, in particular dextrin esters. Also suitable are metal salts of fatty acids, preferably having from 12 to 22 carbon atoms, for example sodium stearate, sodium palmitate, sodium laurate, sodium arachidate, sodium behenate, potassium stearate, potassium palmitate, sodium myristate, aluminum monostearate, hydroxy fatty acids, for example 12-hydroxystearic acid, 16-hydroxyhexadecanoic acid; fatty acid amides; fatty acid alkanolamides; dibenzalsorbitol and alcohol-soluble polyamides and polyacrylamides or mixtures thereof. There can further be used crosslinked and uncrosslinked polyacrylates such as carbomers, sodium polyacrylates or sulfonic-acid-containing polymers such as ammonium acryloyldimethyltaurate/vinylpyrrolidone (VP) copolymer.


There are used as antimicrobial active ingredients, for example, cetyltrimethylammonium chloride, cetylpyridinium chloride, benzethonium chloride, diisobutylethoxyethyldimethylbenzylammonium chloride, sodium N-lauryl sarcosinate, sodium N-palmethyl sarcosinate, lauroyl sarcosine, N-myristoylglycine, potassium N-lauryl sarcosine, trimethylammonium chloride, sodium aluminum chlorohydroxylactate, triethyl citrate, tricetylmethylammonium chloride, 2,4,4′-trichloro-2′-hydroxydiphenyl ether (triclosan), phenoxyethanol, 1,5-pentanediol, 1,6-hexanediol, 3,4,4′-trichlorocarbanilide (triclocarban), diaminoalkylamide, for example L-lysine hexadecylamide, citrate heavy metal salts, salicylates, piroctose, in particular zinc salts, pyrithiones and heavy metal salts thereof, in particular zinc pyrithione, zinc phenolsulfate, farnesol, ketoconazole, oxiconazole, bifonazole, butoconazole, cloconazole, clotrimazole, econazole, enilconazole, fenticonazole, isoconazole, miconazole, sulconazole, tioconazole, fluconazole, itraconazole, terconazole, naftifine and terbinafine, selenium disulfide and octopirox, iodopropynyl butylcarbamate, methylchloroisothiazolinone, methylisothiazolinone, methyldibromo glutaronitrile, AgCl, chloroxylenol, sodium salt of diethylhexyl sulfosuccinate, sodium benzoate, as well as phenoxyethanol, benzyl alcohol, phenoxyisopropanol, parabens, preferably butyl-, ethyl-, methyl- and propyl-paraben, and sodium salts thereof, pentanediol, 1,2-octanediol, 2-bromo-2-nitropropane-1,3-diol, ethylhexylglycerol, benzyl alcohol, sorbic acid, benzoic acid, lactic acid, imidazolidinylurea, diazolidinylurea, dimethyloldimethylhydantoin (DMDMH), sodium salt of hydroxymethyl glycinate, hydroxyethylglycine of sorbic acid, and combinations of these active substances.


The compositions according to the invention can further comprise biogenic active ingredients selected from plant extracts, such as, for example, aloe vera, as well as local anesthetics, antibiotics, antiphlogistics, antiallergics, corticosteroids, sebostatic agents, Bisabolol®, Allantoin®, Phytantriol®, proteins, vitamins selected from niacin, biotin, vitamin B2, vitamin B3, vitamin B6, vitamin B3 derivatives (salts, acids, esters, amides, alcohols), vitamin C and vitamin C derivatives (salts, acids, esters, amides, alcohols), preferably as the sodium salt of the monophosphoric acid ester of ascorbic acid or as the magnesium salt of the phosphoric acid ester of ascorbic acid, tocopherol and tocopherol acetate, as well as vitamin E and/or derivatives thereof.


There can be used as stabilizers metal salts of fatty acids, such as, for example, magnesium stearate, aluminum stearate and/or zinc stearate.


There are available as the moisture-donating substance, for example, isopropyl palmitate, glycerol and/or sorbitol.


There can be used as superfatting agents preferably lanolin and lecithin, non-ethoxylated and polyethoxylated or acylated lanolin and lecithin derivatives, polyol fatty acid esters, mono-, di- and tri-glycerides and/or fatty acid alkanolamides, the latter at the same time acting as foam stabilizers, which are preferably used in amounts of from 0.01 to 10% by weight, particularly preferably from 0.1 to 5.0% by weight and most particularly preferably from 0.5 to 3.0% by weight.


As acids or lyes for adjusting the pH there are preferably used mineral acids, in particular HCl, inorganic bases, in particular NaOH or KOH, or organic acids, in particular citric acid.


Within the scope of a preferred embodiment, the composition comprises

    • (A) from 5 to 15% by weight of component A,
    • (B) from 1 to 10% by weight of component B,
    • (C) from 1 to 10% by weight of component C,
    • (D) from 0.2 to 2.4% by weight of component D,
    • (E) from 5 to 92.8% by weight of component E, wherein component E is a protic solvent,
    • (F) from 0 to 10% by weight of component F,
    • wherein the sum of components A to F is 100% by weight.


Preferably, the composition consists of

    • (A) from 5 to 15% by weight of component A,
    • (B) from 1 to 10% by weight of component B,
    • (C) from 1 to 10% by weight of component C,
    • (D) from 0.2 to 2.4% by weight of component D,
    • (E) from 5 to 92.8% by weight of component E, wherein component E is a protic solvent,
    • (F) from 0 to 10% by weight of component F,
    • wherein the sum of components A to F is 100% by weight.


Within the scope of a further preferred embodiment, the composition comprises

    • (A) from 5 to 10% by weight of component A,
    • (B) from 1 to 7% by weight of component B,
    • (C) from 1 to 7% by weight of component C,
    • (D) from 0.2 to 2.4% by weight of component D,
    • (E) from 5 to 92.8% by weight of component E, wherein component D is a protic solvent,
    • (F) from 0 to 10% by weight of component F,
    • wherein the sum of components A to F is 100% by weight.


Within the scope of a particularly preferred embodiment, the composition comprises

    • (A) from 7 to 10% by weight of component A,
    • (B) from 1 to 5% by weight of component B,
    • (C) from 1 to 5% by weight of component C,
    • (D) from 0.1 to 1.2% by weight of component D,
    • (E) from 5 to 90.8% by weight of component E, wherein component D is a protic solvent,
    • (F) from 0.1 to 5% by weight of component F,
    • wherein the sum of components A to F is 100% by weight.


Within the scope of a preferred embodiment, the sum of components A, B and C is from 7 to 20% by weight, preferably from 10 to 18% by weight and in particular from 10 to 15% by weight.


Preference is given to a ratio of component A:component B:component C of from 2:1:1 to 4:1:1. Particular preference is given to a ratio of 3:1:1.


Within the scope of a preferred embodiment, the composition is a cosmetic, dermatological or pharmaceutical composition.


The invention further provides the use of the composition according to the invention as a shampoo, facial cleanser, liquid cleanser or shower gel.


The invention further provides the use of the composition according to the invention for the treatment or care of the skin.


The invention further provides the use of the composition according to the invention for the treatment or care of the hair.


The invention further provides methods for caring for or treating the skin or hair, wherein the skin or hair is brought into contact with a composition according to the invention.


The invention will be explained in greater detail by the following examples:


Preparation Examples P1 to P3, Example 1 and Comparative Examples 1 to 4.


The N-acyl-N-methyl-glucamines described in the following were prepared according to EP 0 550 637 from the corresponding fatty acid methyl esters or triglycerides and N-methylglucamine in the presence of 1,2-propylene glycol as solvent and were obtained in the form of a solid consisting of active substance and 1,2-propylene glycol. The material obtained in Preparation Examples P1 to P3 comprises the indicated amount of 1,2-propylene glycol and is used directly in the examples shown in Table 2 without being purified further.














TABLE 1








Active
1,2-
Melting


Preparation
Methyl

substance
Propylene
point


Example
ester
Triglyceride
(%)
glycol (%)
(° C.)







P1
C12/14

90
10
85


P2
C8/18

90
10
75



(cocoyl)


P3

C8/18
90
10
50




Coconut oil









C12/14 means that the methyl ester consists of a mixture of lauric acid methyl ester (C12-acyl radical) and myristic acid methyl ester (C14-acyl radical) (ratio 75:25). C8/C18 means that the methyl ester consists of a natural distribution of the fatty acids in coconut oil (octanoic acid methyl ester, decanoic acid methyl ester, lauric acid methyl ester and myristic acid methyl ester, palmitic acid methyl ester, stearic acid methyl ester, oleic acid methyl ester, ratio approximately: 4:7:48:20:10:3:8).


Surfactant solutions consisting of sodium lauryl ether sulfate (Genapol LRO liq., Clariant), cocamidopropyl betaine (Genagen CAB 818, Clariant) and sugar-based surfactants were prepared according to Table 2 below and adjusted to a uniform viscosity of 5000 mPas by addition of sodium chloride. The total surfactant content was in each case 12%.


The products were evaluated by a trained sensory panel with 10 participants in respect of the parameters foam quality, foam creaminess, foaming behavior and amount of foam.


In the evaluation: ++=very good, +=good, o=satisfactory, −=adequate, −−=unsatisfactory, the parameters being evaluated qualitatively against the standard (Comparative Example 4) after determination of the mean.















TABLE 2







Ratio sodium








lauryl ether




sulfate/




cocamido-




propyl



Sugar-
betaine/sugar-



based
based
Foam
Foam
Foaming
Amount


Example
surfactant
surfactant
quality
creaminess
behavior
of foam







Comparative
Preparation
6:2:2



+


Example 1
Example



P1


Comparative
Preparation
6:2:2
+
+
+
+


Example 2
Example



P2


Example 1
Preparation
6:2:2
++
++
++
++



Example



P3


Comparative

7:3






Example 4









As is clear from the results obtained, the use of N-acyl-N-methylglucamines based on C8/18 triglycerides according to Example 1 (e.g. based on coconut oil) leads, in comparison with a corresponding lauroyl derivative (Comparative Example 1) and a coconut derivative based on methyl ester, to an improved sensory evaluation of the foam behavior of the formulation as compared with the prior art.

Claims
  • 1. A composition comprising: (A) at least one anionic surfactant as component A,(B) at least one betaine surfactant as component B selected from the group consisting of an alkyl betaine, an alkylamido betaine and mixtures thereof,(C) a mixture of N-methyl-N-acylglucamines as component C, wherein the N-methyl-N-acylgluamines have a C8-C22-acyl radical and wherein the distribution of the C8-C22-acyl radicals corresponds to that of C8-C22-fatty acids in natural coconut oil, palm kernel oil or a mixture of the two,(D) at least one component D selected from the group consisting of monoglycerides, diglycerides, triglycerides, and mixtures thereof, wherein the glycerides in question have at least one C8-C22-acyl radical and are formed by the transamidation of coconut oil, palm kernel oil or a mixture of the two with an N-methylglucamine,(E) at least one solvent as component E, and(F) optionally one or more additives as component F,wherein components C and D are prepared by transamidation of triglycerides of coconut oil, palm kernel oil or a mixture of the two with N-methylglucamine.
  • 2. The composition as claimed in claim 1, wherein the distribution of the C8-C22-acyl radicals corresponds to that of C8-C22-fatty acids in natural coconut oil.
  • 3. The composition as claimed in claim 1, comprising: (A) from 5 to 15% by weight of component A,(B) from 1 to 10% by weight of component B,(C) from 1 to 10% by weight of component C,(D) from 0.2 to 2.4% by weight of component D,(E) from 5 to 92.8% by weight of component E, wherein component E is a protic solvent, and(F) from 0 to 10% by weight of component F,wherein the sum of components A to F is 100% by weight.
  • 4. The composition as claimed in claim 1, wherein components C and D have been prepared by the reaction of a triglyceride and N-methylglucamine.
  • 5. The composition as claimed in claim 1, wherein component A is selected from the group consisting of one or more compound(s) of formula (I) R1SO3−M+  (I)wherein R1 is alkyl, cycloalkyl, aralkyl, aryl, alkoxy, alkoxyalkyl and heterocyclyl and M+ is an alkali metal, alkaline earth metal or substituted or unsubstituted ammonium ion,and of formula (II) R1SO4−M+  (II)wherein R1 is alkyl, cycloalkyl, aralkyl, aryl, alkoxy, alkoxyalkyl and heterocyclyl and M+ is an alkali metal, alkaline earth metal or substituted or unsubstituted ammonium ion.
  • 6. The composition as claimed in claim 1, wherein component E is water or a mixture of water and propylene glycol.
  • 7. The composition as claimed in claim 1, wherein the sum of components A, B and C is from 7 to 35% by weight.
  • 8. The composition as claimed in claim 1, wherein the one or more additives F are selected from the group consisting of preservatives, fragrances, dyes, further surfactants, water, oily substances, cationic polymers, film-forming agents, thickeners and gelling agents, superfatting agents, antimicrobial and biogenic active ingredients, moisture-donating agents, stabilizers, acids, lyes, activity enhancers, and mixtures thereof.
  • 9. The composition as claimed in claim 1, wherein the composition is a cosmetic, dermatological or pharmaceutical composition.
  • 10. A shampoo, facial cleanser, liquid cleanser or shower gel comprising the composition as claimed in claimed 1.
  • 11. A skin treatment or skin care product comprising a composition as claimed in claim 1.
  • 12. A hair treatment or hair care product comprising a composition as claimed in claim 1.
  • 13. A method for caring for or treating the skin, wherein the skin is brought into contact with a composition as claimed in claim 1.
  • 14. A method for caring for or treating the hair, wherein the hair is brought into contact with a composition as claimed in claim 1.
  • 15. The composition as claimed in claim 1, wherein the distribution of the C8-C22-acyl radicals of component C corresponds to that of C8-C22-fatty acids in natural coconut oil and comprises a) from 40 to 55% by weight lauric acid,b) from 10 to 20% by weight myristic acid,c) from 8 to 12% by weight palmitic acid,d) from 6 to 12% by weight oleic acid, andh) from 0 to 36% by weight further fatty acids,
  • 16. The composition as claimed in claim 1, wherein the distribution of the C8-C22-acyl radicals of component C corresponds to that of C8-C22-fatty acids in natural coconut oil and comprises a) from 40 to 55% by weight lauric acid,b) from 10 to 20% by weight myristic acid,c) from 8 to 12% by weight palmitic acid,d) from 6 to 12% by weight oleic acid,e) from 5 to 10% by weight decanoic acid,f) from 4 to 10% by weight octanoic acid,g) from 1 to 3% by weight stearic acid, andh) from 0 to 26% by weight further fatty acids,
  • 17. A hair treatment or hair care product comprising a composition comprising: (A) at least one anionic surfactant as component A,(B) at least one betaine surfactant as component B selected from the group consisting of an alkyl betaine, an alkylamido betaine and mixtures thereof,(C) a mixture of N-methyl-N-acylglucamines as component C, wherein the mixture of N-methyl-N-acylgluamines have a C8-C22-acyl radical and the distribution of the C8-C22-acyl radicals corresponds to that of C8-C22-fatty acids in natural coconut oil, palm kernel oil or a mixture of the two,(D) at least one component D selected from the group consisting of monoglycerides, diglycerides, triglycerides, wherein the glycerides in question have at least one C8-C22-acyl radical, and are formed by the transamidation of coconut oil, palm kernel oil or a mixture of the two with an N-methylglucamine and mixtures thereof,(E) at least one solvent as component E, and(F) optionally one or more additives as component F,wherein components C and D are prepared by transamidation of triglycerides of coconut oil, palm kernel oil or a mixture of the two with N-methylglucamine.
  • 18. The composition of claim 1, wherein the distribution of the C8-C22-acyl radicals of components C and D are both obtained from C8-C22-fatty acids of a natural coconut oil and components C and D are prepared by transamidation of the triglycerides of the natural coconut oil with N-methylglucamine.
  • 19. The composition of claim 1, wherein the distribution of the C8-C22-acyl radicals of components C and D are both obtained from C8-C22-fatty acids of a natural palm kernel oil and wherein components C and D are prepared by transamidation of the triglycerides of the natural palm kernel oil with N-methylglucamine.
  • 20. The composition of claim 1, wherein the distribution of the C8-C22-acyl radicals of components C and D are both obtained from C8-C22-fatty acids of a mixture of natural coconut oil and natural palm kernel oil and wherein components C and D are prepared by transamidation of the triglycerides of mixture of the natural coconut oil and that natural palm kernel oil with N-methylglucamine.
Priority Claims (1)
Number Date Country Kind
10 2012 010 655 May 2012 DE national
PCT Information
Filing Document Filing Date Country Kind
PCT/EP2013/061065 5/29/2013 WO 00
Publishing Document Publishing Date Country Kind
WO2013/178679 12/5/2013 WO A
US Referenced Citations (173)
Number Name Date Kind
2016962 Flint Oct 1935 A
2667478 Schwartz Jan 1954 A
2703798 Schwartz Mar 1955 A
2891052 Boettner Jun 1959 A
2982737 Boettner May 1961 A
2993887 Zech Jul 1961 A
4079078 Collins Mar 1978 A
4400196 Albrecht Aug 1983 A
4413087 Bernot Nov 1983 A
4481186 Deckner Nov 1984 A
4505827 Rose Mar 1985 A
4565647 Llenado Jan 1986 A
4654207 Preston Mar 1987 A
4681946 Baur Jul 1987 A
4981684 MacKenzie Jan 1991 A
5009814 Kelkenberg Apr 1991 A
5194639 Connor Mar 1993 A
5254281 Pichardo Oct 1993 A
5298195 Brumbaugh Mar 1994 A
5317047 Sabate May 1994 A
5354425 Mackey Oct 1994 A
5449770 Shumate Sep 1995 A
5454982 Murch Oct 1995 A
5500155 Weuthen Mar 1996 A
5539134 Strecker Jul 1996 A
5559078 Garst Sep 1996 A
5560873 Chen Oct 1996 A
5625098 Kao Apr 1997 A
5691299 Fabry Nov 1997 A
5711899 Kawa Jan 1998 A
5712235 Nieendick Jan 1998 A
5716922 Curry Feb 1998 A
5750748 Boutique May 1998 A
5766267 Schumacher Jun 1998 A
5777165 Kao Jul 1998 A
5789372 Fabry Aug 1998 A
5874096 Hazen Feb 1999 A
5945389 Richard Aug 1999 A
6147045 Lappas Nov 2000 A
6147124 Ansmann Nov 2000 A
6165955 Chen Dec 2000 A
6264961 Ansmann Jul 2001 B1
6274126 Newell Aug 2001 B1
6288023 Honda Sep 2001 B1
6329331 Aronson Dec 2001 B1
6350788 Herold Feb 2002 B1
6391962 Zerrer May 2002 B2
6455001 Knappe Sep 2002 B1
6635708 Papenfuhs Oct 2003 B1
6727217 Nieendick Apr 2004 B1
6887838 Dykstra May 2005 B2
6903057 Tsaur Jun 2005 B1
7056379 Nieendick Jun 2006 B2
7217752 Schmucker-Castner May 2007 B2
7250392 Leonard Jul 2007 B1
7297666 Kuepper Nov 2007 B2
7407667 Zerrer Aug 2008 B2
7578995 Frantz Aug 2009 B2
7776318 Bissey-Beugras Aug 2010 B2
7820771 Lapra Oct 2010 B2
7872036 Toriyabe Jan 2011 B2
7897543 Bretschneider Mar 2011 B2
8084452 Jeschke Dec 2011 B2
8178481 Sans May 2012 B2
8263538 Tsaur Sep 2012 B2
8324390 Fischer Dec 2012 B2
8404855 Jeschke Mar 2013 B2
8536340 Hamamoto Sep 2013 B2
8637432 Baur Jan 2014 B2
8729323 Kothandaraman May 2014 B2
8759255 Wacker Jun 2014 B2
8809547 Bretschneider Aug 2014 B2
8901041 Frisch Dec 2014 B2
9187407 Koshti Nov 2015 B2
9504636 Klug Nov 2016 B2
9949909 Klug Apr 2018 B2
1017277 Klug Jan 2019 A1
1026525 Klug Apr 2019 A1
20010023298 Weinelt Sep 2001 A1
20010056048 Bertolosso Dec 2001 A1
20020004476 Pancheri Jan 2002 A1
20020040662 Dietz Apr 2002 A1
20020065198 Highsmith May 2002 A1
20020168417 Blease Nov 2002 A1
20030004929 Julian Jan 2003 A1
20030049292 Turowski-Wanke Mar 2003 A1
20030069153 Jordan Apr 2003 A1
20030199403 Wells Oct 2003 A1
20040086470 Nieendick May 2004 A1
20050037926 Zerrer Feb 2005 A1
20050037942 Otterson Feb 2005 A1
20050172859 Nieendick Aug 2005 A1
20050233935 Gunn Oct 2005 A1
20060058205 Ainger Mar 2006 A1
20060079414 Nieendick Apr 2006 A1
20060089294 Depoot Apr 2006 A1
20060100127 Meier May 2006 A1
20060110415 Gupta May 2006 A1
20060110432 Luu May 2006 A1
20060135382 Molenda Jun 2006 A1
20060142291 Beilfuss Jun 2006 A1
20060166826 Zerrer Jul 2006 A1
20060171979 Calvo Aug 2006 A1
20070054820 Harichian Mar 2007 A1
20070060489 Sun Mar 2007 A1
20070110700 Wells May 2007 A1
20070128144 Bonastre Gilabert Jun 2007 A1
20070190004 Bockmuhl Aug 2007 A1
20070213226 Sieverding Sep 2007 A1
20080057014 Masuda Mar 2008 A1
20080317960 Pitt Dec 2008 A1
20090023622 Leidreiter Jan 2009 A1
20090111847 Li Apr 2009 A1
20090118152 Lam May 2009 A1
20090124498 Von Deyn May 2009 A1
20090253612 Mushock Oct 2009 A1
20090257972 Dieker Oct 2009 A1
20100051200 Mueller Mar 2010 A1
20100285077 Lintner Nov 2010 A1
20100326320 Swedo Dec 2010 A1
20110002865 Fournial Jan 2011 A1
20110146536 Tomlinson Jun 2011 A1
20110150786 Desenne Jun 2011 A1
20110152150 Bernard Jun 2011 A1
20110177945 Klingelhoefer Jul 2011 A1
20110251116 Aehle Oct 2011 A1
20110263471 Barnhart Oct 2011 A1
20120009127 Dasgupta Jan 2012 A1
20120010113 Hee Jan 2012 A1
20120070388 Man Mar 2012 A1
20120094890 Anantaneni Apr 2012 A1
20120172223 Wacker Jul 2012 A1
20120244092 Moser Sep 2012 A1
20130030197 Harichian Jan 2013 A1
20130189212 Jawale Jul 2013 A1
20130216491 Ogihara Aug 2013 A1
20140135245 Annaheim May 2014 A1
20140230841 Mathonneau Aug 2014 A1
20140255330 Cron Sep 2014 A1
20140303389 Crosby Oct 2014 A1
20150032003 Cho Jan 2015 A1
20150125415 Klug et al. May 2015 A1
20150126424 Klug et al. May 2015 A1
20150126616 Klug et al. May 2015 A1
20150133560 Klug et al. May 2015 A1
20150140048 Klug et al. May 2015 A1
20150141466 Klug et al. May 2015 A1
20150141508 Klug et al. May 2015 A1
20150150767 Klug et al. Jun 2015 A1
20150164755 Klug et al. Jun 2015 A1
20150164756 Klug et al. Jun 2015 A1
20150282478 Baur Oct 2015 A1
20150320037 Wacker Nov 2015 A1
20150335550 Koshti Nov 2015 A1
20160074310 Klug et al. Mar 2016 A1
20160136072 Klug et al. May 2016 A1
20160143828 Klug et al. May 2016 A1
20160243014 Dahms et al. Aug 2016 A1
20160272666 Klug et al. Sep 2016 A1
20160361243 Klug et al. Dec 2016 A1
20170000710 Klug et al. Jan 2017 A1
20170002297 Klug et al. Jan 2017 A1
20170044434 Baur et al. Feb 2017 A1
20170055524 Baur et al. Mar 2017 A1
20170071199 Baur et al. Mar 2017 A1
20170101606 Klug et al. Apr 2017 A1
20170218293 Klug et al. Aug 2017 A1
20170226349 Kupfer Aug 2017 A1
20170265477 Baur et al. Sep 2017 A1
20170292062 Wylde et al. Oct 2017 A1
20170305838 Appel et al. Oct 2017 A1
20180215879 Kupfer Aug 2018 A1
20190076344 Klug Mar 2019 A1
Foreign Referenced Citations (190)
Number Date Country
2117007 Sep 1994 CA
1333226 Nov 1994 CA
2127644 Jan 1995 CA
1061960 Jun 1992 CN
1077489 Oct 1993 CN
1078746 Nov 1993 CN
1088258 Jun 1994 CN
1140987 Jan 1997 CN
1141653 Jan 1997 CN
1155239 Jul 1997 CN
1292641 Apr 2001 CN
1296524 May 2001 CN
1501772 Jun 2004 CN
1518408 Aug 2004 CN
1594518 Mar 2005 CN
100528887 May 2006 CN
1997341 Jul 2007 CN
102186340 Sep 2011 CN
102595882 Jul 2012 CN
103468362 Dec 2013 CN
103468382 Dec 2013 CN
104918490 Sep 2015 CN
1956509 May 1971 DE
2226872 Dec 1973 DE
4238211 Jan 1994 DE
4235783 Apr 1994 DE
4435383 Nov 1995 DE
19507531 Sep 1996 DE
19701127 Jul 1998 DE
19808824 Oct 1999 DE
19846429 Apr 2000 DE
19916090 Oct 2000 DE
10117993 Oct 2002 DE
10130357 Jan 2003 DE
102007034438 Jan 2009 DE
202013011412 Jan 2014 DE
202013011413 Jan 2014 DE
102012021647 May 2014 DE
0039860 Nov 1981 EP
0048436 Mar 1982 EP
0285768 Oct 1988 EP
0285786 Oct 1988 EP
0336151 Oct 1989 EP
0378985 Jul 1990 EP
0407874 Jan 1991 EP
0539588 May 1993 EP
0 550 637 Jul 1993 EP
0572723 Dec 1993 EP
0614881 Sep 1994 EP
0633244 Jan 1995 EP
0709449 May 1996 EP
0745719 Dec 1996 EP
0769548 Apr 1997 EP
0774503 May 1997 EP
0995994 Apr 2000 EP
1043017 Oct 2000 EP
1 078 978 Feb 2001 EP
1093722 Apr 2001 EP
1110944 Jun 2001 EP
1177223 Feb 2002 EP
1379129 Jan 2004 EP
1422288 May 2004 EP
1529832 May 2005 EP
1676831 Jul 2006 EP
1716842 Nov 2006 EP
S4810053 Feb 1973 JP
S63270534 Nov 1988 JP
H06501731 Feb 1994 JP
H06501733 Feb 1994 JP
H06240599 Aug 1994 JP
H07507341 Aug 1995 JP
H0812993 Jan 1996 JP
H0848618 Feb 1996 JP
H09502476 Mar 1997 JP
H09506683 Jun 1997 JP
H09510956 Nov 1997 JP
H10501279 Feb 1998 JP
H10508043 Aug 1998 JP
H11505839 May 1999 JP
H11246890 Sep 1999 JP
H11512334 Oct 1999 JP
2000512286 Sep 2000 JP
2000297028 Oct 2000 JP
2001501635 Feb 2001 JP
2001131579 May 2001 JP
2001247528 Sep 2001 JP
2002542344 Dec 2002 JP
2006183030 Jul 2006 JP
2006183039 Jul 2006 JP
2007538023 Dec 2007 JP
2008110953 May 2008 JP
2010018586 Jan 2010 JP
2010037252 Feb 2010 JP
2013534232 Sep 2013 JP
2014532815 Dec 2014 JP
2015518026 Jun 2015 JP
2017526776 Sep 2017 JP
9205764 Apr 1992 WO
9206073 Apr 1992 WO
9206154 Apr 1992 WO
9206162 Apr 1992 WO
WO 9206158 Apr 1992 WO
WO9206161 Apr 1992 WO
WO 9206161 Apr 1992 WO
WO-9206161 Apr 1992 WO
9318125 Sep 1993 WO
9319149 Sep 1993 WO
9410130 May 1994 WO
9412608 Jun 1994 WO
9412609 Jun 1994 WO
9419941 Sep 1994 WO
9516824 Jun 1995 WO
9517880 Jul 1995 WO
9519415 Jul 1995 WO
9523840 Sep 1995 WO
9533033 Dec 1995 WO
9533035 Dec 1995 WO
WO 9603974 Feb 1996 WO
9610386 Apr 1996 WO
9614374 May 1996 WO
9616540 Jun 1996 WO
9628023 Sep 1996 WO
9637589 Nov 1996 WO
9637592 Nov 1996 WO
9747284 Dec 1997 WO
9800496 Jan 1998 WO
9841601 Sep 1998 WO
WO 9856496 Dec 1998 WO
9951716 Oct 1999 WO
0065014 Nov 2000 WO
0137658 May 2001 WO
0160877 Aug 2001 WO
02089575 Nov 2002 WO
2002096882 Dec 2002 WO
03000055 Jan 2003 WO
2003106457 Dec 2003 WO
2004056358 Jul 2004 WO
2004099150 Nov 2004 WO
2004099160 Nov 2004 WO
2005035486 Apr 2005 WO
2005063094 Jul 2005 WO
2005077934 Aug 2005 WO
2005117580 Dec 2005 WO
2006043635 Apr 2006 WO
2006056433 Jun 2006 WO
2006089633 Aug 2006 WO
2006100288 Sep 2006 WO
2007040280 Apr 2007 WO
2007057407 May 2007 WO
2007075459 Jul 2007 WO
2007101369 Sep 2007 WO
2007115643 Oct 2007 WO
2007115644 Oct 2007 WO
2007115646 Oct 2007 WO
2007147500 Dec 2007 WO
2007149134 Dec 2007 WO
WO-2007141066 Dec 2007 WO
2005085216 Jan 2008 WO
2008009360 Jan 2008 WO
2008066153 Jun 2008 WO
2008067911 Jun 2008 WO
2008104503 Sep 2008 WO
2009002956 Dec 2008 WO
2009029561 Mar 2009 WO
2009049851 Apr 2009 WO
2010005692 Jan 2010 WO
2010006713 Jan 2010 WO
2010069502 Jun 2010 WO
2010074747 Jul 2010 WO
2010074751 Jul 2010 WO
2010126657 Nov 2010 WO
2010138661 Dec 2010 WO
2011138450 Nov 2011 WO
2012061991 May 2012 WO
2012116939 Sep 2012 WO
2013016270 Jan 2013 WO
2013178668 Dec 2013 WO
2013178670 Dec 2013 WO
2013178671 Dec 2013 WO
2013178679 Dec 2013 WO
2013178697 Dec 2013 WO
2013178700 Dec 2013 WO
2013178701 Dec 2013 WO
2014056561 Apr 2014 WO
2014067663 May 2014 WO
2014170025 Oct 2014 WO
2015082062 Jun 2015 WO
2015124302 Aug 2015 WO
2016023693 Feb 2016 WO
2016041823 Mar 2016 WO
Non-Patent Literature Citations (77)
Entry
The Chemistry of Coconut Oil, accessed online Jul. 12, 2018 (Year: 2018).
U.S. Appl. No. 14/401,315, now published as US 2015-0133560.
U.S. Appl. No. 14/401,323, now published as US 2015-0141508.
U.S. Appl. No. 14/401,337, now published as US 2015-0141466.
U.S. Appl. No. 14/401,789, now published as US 2015-0126616.
U.S. Appl. No. 14/402,954, now published as US 2015-0140048.
U.S. Appl. No. 14/899,835, now published as US 2016-0143828.
U.S. Appl. No. 14/402,996, now published as US 2015-0164755.
U.S. Appl. No. 14/403,049, now published as US 2015-0150767.
U.S. Appl. No. 14/403,072, now published as US 2015-0164756.
U.S. Appl. No. 14/401,796, now published as US 2015-0126424.
U.S. Appl. No. 14/439,052, now published as US 2015-0320037.
U.S. Appl. No. 14/785,599, now published as US 2016-0074310.
U.S. Appl. No. 14/901,090, now published as US 2016-0136072.
U.S. Appl. No. 15/037,172, now published as US 2016-0272666.
U.S. Appl. No. 15/100,165, now published as US 2017-0002297.
U.S. Appl. No. 15/039,970, now published as US 2016-0361243.
U.S. Appl. No. 15/100,039, now published as US 2017-0000710.
U.S. Appl. No. 15/035,120, now published as US 2016-0243014.
U.S. Appl. No. 15/526,464, now published as US 2017-0305838.
U.S. Appl. No. 15/120,097, now published as US 2017-0071199.
U.S. Appl. No. 15/120,103, now published as US 2017-0055524.
U.S. Appl. No. 15/123,065, now published as US 2017-0101606.
U.S. Appl. No. 15/123,143, now published as US 2017-0218293.
U.S. Appl. No. 15/307,205, now published as US 2017-0044434.
U.S. Appl. No. 15/515,324, now published as US 2017-0265477.
U.S. Appl. No. 15/511,987, now published as US 2017-0292062.
U.S. Appl. No. 14/662,564.
U.S. Appl. No. 14/677,500.
U.S. Appl. No. 14/491,615.
U.S. Appl. No. 15/562,852.
U.S. Appl. No. 15/744,645.
English Abstract for DE 4435383, Nov. 9, 1995.
English Abstract for DE 19507531, Sep. 12, 1996.
International Search Report for PCT/EP2013/061100, dated Jul. 16, 2014.
Bezard (Lipids 1971;6:630-634).
Dale et al. (J. Sci. Food. Agric. 1955;6:166-170) (Year: 1955).
English Translation of Cited Excerpts of CN103468382A, Dec. 25, 2013. 2 pages.
Friedrich Vogel: “Kosmetik aus der Sicht des Chemikers”, Chemie in Unserer Zeit, No. 5, Jan. 1, 1986, pp. 156-164, XP055109030, DOI: 10.1002/ciuz.19860200504 p. 160.
Hardcopy of http://igf-bingen.de/Croda_produkte.pdf, Dec. 1, 2016. 3 pages.
International Preliminary Report on Patentability for PCT/EP2013/061044, dated Feb. 12, 2014. 7 pages.
International Preliminary Report on Patentability for PCT/EP2014/001723, dated Jun. 8, 2015. 16 pages.
International Preliminary Report on Patentability for PCT/EP2015/000443, dated Jan. 22, 2016. 6 pages.
International Preliminary Report on Patentability for PCT/EP2015/076072, dated May 16, 2017. 5 pages.
International Search Report for PCT/EP2013/061044, dated May 15, 2014. 2 pages.
International Search Report for PCT/EP2013/061047, dated May 22, 2014. 3 pages.
International Search Report for PCT/EP2013/061075, dated May 15, 2014. 2 pages.
International Search Report for PCT/EP2013/061076, mail date May 15, 2014.2 pages.
International Search Report for PCT/EP2013/061100, dated Jul. 15, 2014. 4 pages.
International Search Report for PCT/EP2014/001723, dated Jan. 5, 2015. 3 pages.
International Search Report for PCT/EP2015/000443, dated Jun. 2, 2015.2 pages.
International Search Report for PCT/EP2015/000871 dated Jul. 15, 2015. 3 pages.
International Search Report for PCT/EP2015/076072, dated Feb. 29, 2016. 2 pages.
Palm fatty acid distillate (PFAD) [online] retrieved on May 21, 2018 from: https://www.neste.com/ corporate-info/sustainability/sustainable-supply-chain/pfad-residue-palm-oil-refining-process; 1 page. (Year: 2018).
Plante et al. Castor Oil [online] retrieved on 1/13/16 from: http://www.dionex.com/en-us/ webdocs/110518-Po-UHPLC-Castor-Oil-31May2011-LPN2822-01.pdf; 5 pages.
PubChem, Methylmeglumine, 2006. (Year: 2006) 9 pages.
Quack, et al., Fette-Seifen-Anstrichmittel 78, 200(1976). 7 pages.
R. Mohammadi, J. Wassink, a. Amirfazli, “Effect of Surfactants on Wetting of Super-Hydrophobic Surfaces”, Langmuir, American Chemical Society, (20041001), vol. 20, No. 22, doi:10.1021/ la049268k, ISSN 07437463, pp. 9657-9662, XP055098502.
Smith, J.T. et al., “Micellar Electrokinetic Capillary Chromatography with in Situ Charged Micelles. 1. Evaluation of N-D-Gluco-N-methylalkanamide Surfactants as Anionic Borate Complexes,” Anal. Chem. 1994, 66, 1119-1133.
Söderlind, E. et al., “The usefulness of sugar surfactants as solubilizing agents in parenteral formulations,” Elsevier, I nternational !IJournal of Pharmaceutics 252 (2003) pp. 61-71, Aug. 19, 2002.
Study on Synthesis and Properties of “Green” Surfactants—Glucamine derivates, Zhao Handong, Master Thesis, Southern Yangtze University, pp. 5-6, Jul. 25, 2007.
Tan et al. (Appl Microbiol Biotechnol. 47:207-211) (Year: 1997).
Tegeler, T. et al., Special Guest Editor Section: Electrically Driven Microseparation Methods for Pesticides and Metabolites: I. Micellar Electrokinetic Capillary Chromatography of Carbamate Insecticides with Mega-Borate and SDS Surfactants,″ Journal of AOAC International, vol. 82, No. 6, pp. 1542-1549, Nov. 6, 1999.
V. Bergeron, P. Cooper, C. Fischer. J. Giermanska-Kahn, D. Langevin, and a. Pouchelon, “Polydimethylsiloxane (PDMS)-based antifoams” Colloids and Surfaces A: Physicochemical and Engineering Aspects 122 (1997) 103 120. 18 pages.
Walter, a. ; Suchy, S.E. ; Vinson, P.K., “Solubility properties of the alkylmethylglucamide surfactants”, Biochimica et Biophysica Acta (BBA)-Biomembranes, Elsevier, Amsterdam, NL, Amsterdam, NL, (19901102), vol. 1029, No. 1, doi:10.1016/0005-2736(90)90437-S, ISSN 0005-2736, pp. 67-74, XP023354648.
Zhu, Y-P, et al., “Surface Properties of N-Alkanoyl-N-Methy Glucamines and Related Materials”, J. Of Surfactants and Detergents, vol. 2, No. 3, Jul. 1, 1999.6 pages.
Lichtenthaler, F.W., “Carbohydrates as Organic Raw Materials,” in Ullmann's Encyclopedia of Industrial Chemistry, Wiley-VCH Verlag, 2010. (34 pages).
“Product Specification: N-octanoyl-N-methylglucamine”, Jun. 29, 2000 (Jun. 29, 2000), pp. 1-1, XP055098500, Retrieved from the Internet: Url:http://www.sigmaaldrich.com/Graphics/COfAlnfo/ SigmaSAPQM/Spec/03/03129/03129 -BULKSIGMA.pdf.
European Coatings Journal in 2009, vol. 07, pp. 26-28.
International Preliminary Report on Patentability for PCT/EP2016/071750, dated Apr. 10, 2018, 5 pages.
International Search Report for PCT/EP2013/003290, dated Feb. 10, 2014. 5 pages.
International Search Report for PCT/EP2014/001722, dated Jan. 5, 2015. 3 pages.
International Search Report for PCT/EP2015/072453, dated Oct. 23, 2015. 2 pages.
International Search Report for PCT/EP2016/063433, dated Aug. 24, 2016. 2 pages.
International Search Report for PCT/EP2016/071750, dated Jan. 28, 2017, 3 pages.
International Search Report for PCT/EP2016/074085, dated Jan. 3, 2017, 3 pages.
Synergen OS Innovation Spotlight, Sep. 1, 2013, 5 pages.
Related Publications (1)
Number Date Country
20150125415 A1 May 2015 US